Neuropace, Inc. - stock earnings
NPCE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -6.2 million USD | 18.0 million USD |
| 2023Q3 | -7.3 million USD | 16.4 million USD |
| 2023Q2 | -9.1 million USD | 16.5 million USD |
| 2023Q1 | -14.4 million USD | 14.5 million USD |
| 2022Q4 | -12.4 million USD | 12.8 million USD |
| 2022Q3 | -13.4 million USD | 11.2 million USD |
| 2022Q2 | -14.4 million USD | 10.2 million USD |
| 2022Q1 | -13.2 million USD | 11.4 million USD |
| 2021Q4 | -10.7 million USD | 11.0 million USD |
| 2021Q3 | -8.1 million USD | 10.3 million USD |
| 2021Q2 | -8.5 million USD | 12.6 million USD |
| 2021Q1 | -8.8 million USD | 11.2 million USD |
| 2020Q4 | -4.6 million USD | 10.8 million USD |
| 2020Q3 | -4.1 million USD | 12.8 million USD |
| 2020Q2 | -8.8 million USD | 7.6 million USD |
| 2020Q1 | -6.7 million USD | 10.0 million USD |
NPCE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -33.0 million USD | 65.4 million USD |
| 2022 | -53.4 million USD | 45.5 million USD |
| 2021 | -38.1 million USD | 45.2 million USD |
| 2020 | -36.0 million USD | 41.1 million USD |
| 2019 | -40.7 million USD | 37.0 million USD |
NPCE
Price: $13.64
52 week price:
Earnings Per Share: -1.27 USD
P/E Ratio: -10.80
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Volume: 24800
Market Capitalization: 391.7 million